Bengaluru, Feb. 28 -- Marking Rare Disease Day, Strand Life Sciences, a subsidiary of Reliance Industries and a leading genomics research company, has launched the StrandOmics Portal, an innovative digital platform designed to assist doctors in diagnosing rare diseases more efficiently.

The newly introduced portal provides clinicians with rapid and detailed insights into genetic variants, offering a comprehensive and accurate assessment for each patient.

This advancement is expected to enhance the speed and precision of rare disease diagnoses, ultimately benefiting patients who often face prolonged diagnostic journeys.

Alongside the launch of the StrandOmics Portal, the company has announced a special initiative to offer genetic testin...